Skip to main content
Fig. 6 | Journal of Ovarian Research

Fig. 6

From: Mechanisms of He Shi Yu Lin formula in treating premature ovarian insufficiency: insights from network pharmacology and animal experiments

Fig. 6

Molecular docking results of HSYLF with high binding energy. A STAT3 and licochalcone A; B Jun and formononetin; C MAPK3 and naringenin; D TP53 and quercetin; E HSP90AA1 and 1,6-dihydroxy-5-methoxy-2-(methoxymethyl)-9,10-anthraquinone. HSYLF, He Shi Yu Lin Formula; STAT3, signal transduction and activator of transcription; Jun, Jun proto-oncogene; MAPK3: mitogen-activated protein kinase 3; TP53, tumor protein P53; HSP90AA1, heat shock protein 90 alpha family class A member 1

Back to article page